Annual Revenue
$62.84 M
+$9.94 M+18.78%
December 31, 2022
Summary
- As of March 2, 2025, SRNE annual revenue is $62.84 million, with the most recent change of +$9.94 million (+18.78%) on December 31, 2022.
- During the last 3 years, SRNE annual revenue has risen by +$31.41 million (+99.92%).
- SRNE annual revenue is now -58.62% below its all-time high of $151.86 million, reached on December 31, 2017.
Performance
SRNE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$15.03 M
-$1.23 M-7.54%
June 30, 2023
Summary
- As of March 2, 2025, SRNE quarterly revenue is $15.03 million, with the most recent change of -$1.23 million (-7.54%) on June 30, 2023.
- Over the past year, SRNE quarterly revenue has dropped by -$1.23 million (-7.54%).
- SRNE quarterly revenue is now -87.68% below its all-time high of $121.91 million, reached on September 30, 2017.
Performance
SRNE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$64.27 M
+$3.56 M+5.87%
June 30, 2023
Summary
- As of March 2, 2025, SRNE TTM revenue is $64.27 million, with the most recent change of +$3.56 million (+5.87%) on June 30, 2023.
- Over the past year, SRNE TTM revenue has increased by +$3.56 million (+5.87%).
- SRNE TTM revenue is now -58.06% below its all-time high of $153.23 million, reached on March 31, 2018.
Performance
SRNE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
SRNE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.8% | -7.5% | +5.9% |
| 3 y3 years | +99.9% | -7.5% | +5.9% |
| 5 y5 years | -58.6% | -7.5% | +5.9% |
SRNE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.8% | -18.3% | +31.1% | at high | +21.5% |
| 5 y | 5-year | at high | +99.9% | -18.3% | +94.6% | at high | +104.5% |
| alltime | all time | -58.6% | >+9999.0% | -87.7% | >+9999.0% | -58.1% | >+9999.0% |
Sorrento Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $15.03 M(-7.5%) | $64.27 M(+5.9%) |
| Mar 2023 | - | $16.25 M(+4.2%) | $60.71 M(-3.4%) |
| Dec 2022 | $62.84 M(+18.8%) | $15.59 M(-10.4%) | $62.84 M(+4.2%) |
| Sep 2022 | - | $17.40 M(+51.8%) | $60.32 M(+9.7%) |
| Jun 2022 | - | $11.46 M(-37.7%) | $54.98 M(-3.6%) |
| Mar 2022 | - | $18.39 M(+40.6%) | $57.03 M(+7.8%) |
| Dec 2021 | $52.90 M(+32.3%) | $13.08 M(+8.4%) | $52.90 M(+3.1%) |
| Sep 2021 | - | $12.06 M(-10.7%) | $51.33 M(+0.6%) |
| Jun 2021 | - | $13.51 M(-5.2%) | $51.02 M(+9.7%) |
| Mar 2021 | - | $14.26 M(+23.9%) | $46.52 M(+16.3%) |
| Dec 2020 | $39.99 M(+27.2%) | $11.51 M(-2.1%) | $39.99 M(-3.7%) |
| Sep 2020 | - | $11.75 M(+30.5%) | $41.52 M(+16.8%) |
| Jun 2020 | - | $9.01 M(+16.7%) | $35.54 M(+7.7%) |
| Mar 2020 | - | $7.72 M(-40.8%) | $33.01 M(+5.0%) |
| Dec 2019 | $31.43 M(+48.3%) | $13.03 M(+125.6%) | $31.43 M(+24.1%) |
| Sep 2019 | - | $5.78 M(-10.8%) | $25.33 M(+7.1%) |
| Jun 2019 | - | $6.48 M(+5.4%) | $23.65 M(+12.2%) |
| Mar 2019 | - | $6.14 M(-11.3%) | $21.09 M(-0.5%) |
| Dec 2018 | $21.19 M(-86.0%) | $6.93 M(+68.8%) | $21.19 M(-38.9%) |
| Sep 2018 | - | $4.11 M(+4.9%) | $34.67 M(-77.3%) |
| Jun 2018 | - | $3.91 M(-37.4%) | $152.48 M(-0.5%) |
| Mar 2018 | - | $6.25 M(-69.4%) | $153.23 M(+0.9%) |
| Dec 2017 | $151.86 M(+1762.8%) | $20.41 M(-83.3%) | $151.86 M(+12.1%) |
| Sep 2017 | - | $121.91 M(+2513.3%) | $135.47 M(+757.3%) |
| Jun 2017 | - | $4.67 M(-4.3%) | $15.80 M(+31.3%) |
| Mar 2017 | - | $4.87 M(+21.3%) | $12.04 M(+47.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $8.15 M(+77.6%) | $4.02 M(+79.2%) | $8.15 M(+49.0%) |
| Sep 2016 | - | $2.24 M(+148.7%) | $5.47 M(+26.3%) |
| Jun 2016 | - | $902.00 K(-8.7%) | $4.33 M(-5.9%) |
| Mar 2016 | - | $988.00 K(-26.1%) | $4.60 M(+0.2%) |
| Dec 2015 | $4.59 M(+20.0%) | $1.34 M(+21.2%) | $4.59 M(+13.3%) |
| Sep 2015 | - | $1.10 M(-6.0%) | $4.05 M(-4.1%) |
| Jun 2015 | - | $1.17 M(+20.1%) | $4.22 M(+10.4%) |
| Mar 2015 | - | $977.00 K(+22.4%) | $3.83 M(+0.0%) |
| Dec 2014 | $3.83 M(+731.5%) | $798.00 K(-37.5%) | $3.83 M(+22.3%) |
| Sep 2014 | - | $1.28 M(+64.6%) | $3.13 M(+61.7%) |
| Jun 2014 | - | $775.00 K(-20.6%) | $1.94 M(+48.6%) |
| Mar 2014 | - | $976.00 K(+866.3%) | $1.30 M(+183.0%) |
| Dec 2013 | $460.00 K(-21.2%) | $101.00 K(+21.7%) | $460.00 K(-4.4%) |
| Sep 2013 | - | $83.00 K(-41.5%) | $481.20 K(-9.7%) |
| Jun 2013 | - | $142.00 K(+6.0%) | $532.70 K(-12.4%) |
| Mar 2013 | - | $134.00 K(+9.7%) | $607.80 K(+4.1%) |
| Dec 2012 | $584.00 K(+10.4%) | $122.20 K(-9.1%) | $583.90 K(-1.0%) |
| Sep 2012 | - | $134.50 K(-38.0%) | $589.60 K(+7.8%) |
| Jun 2012 | - | $217.10 K(+97.2%) | $546.90 K(+35.4%) |
| Mar 2012 | - | $110.10 K(-13.9%) | $404.00 K(-23.7%) |
| Dec 2011 | $529.20 K(-22.5%) | $127.90 K(+39.3%) | $529.30 K(-42.0%) |
| Sep 2011 | - | $91.80 K(+23.7%) | $913.20 K(-2.4%) |
| Jun 2011 | - | $74.20 K(-68.5%) | $935.70 K(+1.9%) |
| Mar 2011 | - | $235.40 K(-54.0%) | $918.00 K(+34.5%) |
| Dec 2010 | $682.60 K | $511.80 K(+347.8%) | $682.60 K(+299.6%) |
| Sep 2010 | - | $114.30 K(+102.3%) | $170.80 K(+202.3%) |
| Jun 2010 | - | $56.50 K | $56.50 K |
FAQ
- What is Sorrento Therapeutics annual revenue?
- What is the all time high annual revenue for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual revenue year-on-year change?
- What is Sorrento Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly revenue year-on-year change?
- What is Sorrento Therapeutics TTM revenue?
- What is the all time high TTM revenue for Sorrento Therapeutics?
- What is Sorrento Therapeutics TTM revenue year-on-year change?
What is Sorrento Therapeutics annual revenue?
The current annual revenue of SRNE is $62.84 M
What is the all time high annual revenue for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual revenue is $151.86 M
What is Sorrento Therapeutics annual revenue year-on-year change?
Over the past year, SRNE annual revenue has changed by +$9.94 M (+18.78%)
What is Sorrento Therapeutics quarterly revenue?
The current quarterly revenue of SRNE is $15.03 M
What is the all time high quarterly revenue for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly revenue is $121.91 M
What is Sorrento Therapeutics quarterly revenue year-on-year change?
Over the past year, SRNE quarterly revenue has changed by -$1.23 M (-7.54%)
What is Sorrento Therapeutics TTM revenue?
The current TTM revenue of SRNE is $64.27 M
What is the all time high TTM revenue for Sorrento Therapeutics?
Sorrento Therapeutics all-time high TTM revenue is $153.23 M
What is Sorrento Therapeutics TTM revenue year-on-year change?
Over the past year, SRNE TTM revenue has changed by +$3.56 M (+5.87%)